Protagenic Therapeutics (PTIX) Revenue & Revenue Breakdown
Protagenic Therapeutics Revenue Highlights
Protagenic Therapeutics Revenue by Period
Protagenic Therapeutics Revenue by Year
| Date | Revenue | Change |
|---|---|---|
| 2023-12-31 | - | 100.00% |
| 2022-12-31 | - | 100.00% |
| 2021-12-31 | - | 100.00% |
| 2020-12-31 | - | 100.00% |
| 2019-12-31 | - | 100.00% |
| 2018-12-31 | - | 100.00% |
| 2017-12-31 | - | 100.00% |
| 2016-12-31 | - | 100.00% |
| 2015-06-30 | - | 100.00% |
| 2014-06-30 | - | -100.00% |
| 2013-06-30 | $85.00K | -99.79% |
| 2010-12-31 | $40.03M | -42.07% |
| 2009-12-31 | $69.09M | -39.33% |
| 2008-12-31 | $113.88M | 207.94% |
| 2007-12-31 | $36.98M | 97.54% |
| 2006-12-31 | $18.72M | 100.00% |
| 2005-07-31 | - | 100.00% |
| 2004-07-31 | - | 100.00% |
| 2003-07-31 | - | -100.00% |
| 2002-07-31 | $18.57M | -14.12% |
| 2001-07-31 | $21.63M | 1.11% |
| 2000-07-31 | $21.39M | 13.99% |
| 1999-07-31 | $18.76M | 20.16% |
| 1998-07-31 | $15.62M | 24.19% |
| 1997-07-31 | $12.57M | 27.00% |
| 1996-07-31 | $9.90M | 43.48% |
| 1995-07-31 | $6.90M | - |
Protagenic Therapeutics generated - in revenue during NA 2023, up 100.00% compared to the previous quarter, and up NaN% compared to the same period a year ago.
Protagenic Therapeutics Revenue by Quarter
| Date | Revenue | Change |
|---|---|---|
| 2024-06-30 | - | 100.00% |
| 2024-03-31 | - | -100.00% |
| 2023-12-31 | $3.20K | 100.00% |
| 2023-09-30 | - | 100.00% |
| 2023-06-30 | - | 100.00% |
| 2023-03-31 | - | 100.00% |
| 2022-12-31 | - | 100.00% |
| 2022-09-30 | - | 100.00% |
| 2022-06-30 | - | 100.00% |
| 2022-03-31 | - | -100.00% |
| 2021-12-31 | $-480.51K | 100.00% |
| 2021-09-30 | - | 100.00% |
| 2021-06-30 | - | 100.00% |
| 2021-03-31 | - | 100.00% |
| 2020-12-31 | - | 100.00% |
| 2020-09-30 | - | 100.00% |
| 2020-06-30 | - | 100.00% |
| 2020-03-31 | - | 100.00% |
| 2019-12-31 | - | 100.00% |
| 2019-09-30 | - | 100.00% |
| 2019-06-30 | - | 100.00% |
| 2019-03-31 | - | 100.00% |
| 2018-12-31 | - | 100.00% |
| 2018-09-30 | - | 100.00% |
| 2018-06-30 | - | 100.00% |
| 2018-03-31 | - | 100.00% |
| 2017-12-31 | - | 100.00% |
| 2017-09-30 | - | 100.00% |
| 2017-06-30 | - | 100.00% |
| 2017-03-31 | - | 100.00% |
| 2016-12-31 | - | 100.00% |
| 2016-09-30 | - | 100.00% |
| 2016-06-30 | - | 100.00% |
| 2016-03-31 | - | 100.00% |
| 2015-12-31 | - | 100.00% |
| 2015-09-30 | - | 100.00% |
| 2015-06-30 | - | 100.00% |
| 2015-03-31 | - | 100.00% |
| 2014-12-31 | - | 100.00% |
| 2014-09-30 | - | 100.00% |
| 2014-06-30 | - | 100.00% |
| 2014-03-31 | - | 100.00% |
| 2013-12-31 | - | 100.00% |
| 2013-09-30 | - | -100.00% |
| 2011-09-30 | $12.33M | 96.59% |
| 2011-06-30 | $6.27M | -11.13% |
| 2011-03-31 | $7.05M | -9.97% |
| 2010-12-31 | $7.84M | -14.61% |
| 2010-09-30 | $9.18M | -15.13% |
| 2010-06-30 | $10.81M | -11.37% |
| 2010-03-31 | $12.20M | -10.69% |
| 2009-12-31 | $13.66M | -8.16% |
| 2009-09-30 | $14.87M | -12.55% |
| 2009-06-30 | $17.01M | -27.77% |
| 2009-03-31 | $23.55M | 2.94% |
| 2008-12-31 | $22.88M | -25.77% |
| 2008-09-30 | $30.82M | -2.01% |
| 2008-06-30 | $31.45M | 9.44% |
| 2008-03-31 | $28.74M | 105.99% |
| 2007-12-31 | $13.95M | 32.93% |
| 2007-09-30 | $10.49M | 52.23% |
| 2007-06-30 | $6.89M | 22.19% |
| 2007-03-31 | $5.64M | 100.00% |
| 2006-10-31 | - | 100.00% |
| 2006-07-31 | - | 100.00% |
| 2006-04-30 | - | 100.00% |
| 2006-01-31 | - | - |
Protagenic Therapeutics generated - in revenue during Q2 2024, up 100.00% compared to the previous quarter, and up NaN% compared to the same period a year ago.
Protagenic Therapeutics Peer Comparison by Revenue
PTIX Revenue FAQ
What is Protagenic Therapeutics’s yearly revenue?
Protagenic Therapeutics's yearly revenue for 2023 was $0, representing an increase of 100.00% compared to 2022. The company's yearly revenue for 2022 was $0, representing an increase of 100.00% compared to 2021. PTIX's yearly revenue for 2021 was $0, representing an increase of 100.00% compared to 2020.
What is Protagenic Therapeutics’s quarterly revenue?
Protagenic Therapeutics's quarterly revenue for Q2 2024 was $0, a 100.00% increase from the previous quarter (Q1 2024), and a 0% increase year-over-year (Q2 2023). The company's quarterly revenue for Q1 2024 was $0, a -100.00% decrease from the previous quarter (Q4 2023), and a 0% increase year-over-year (Q1 2023). PTIX's quarterly revenue for Q4 2023 was $3.2K, a 100.00% increase from the previous quarter (Q3 2023), and a 0% increase year-over-year (Q4 2022).
What is Protagenic Therapeutics’s revenue growth rate?
Protagenic Therapeutics's revenue growth rate for the last 3 years (2021-2023) was 0%, and for the last 5 years (2019-2023) was 0%.